Deferasirox oral
NDC 67877-675, Deferasirox oral, granule, from Ascend Laboratories, LLC.
- Product NDC
- 67877-675
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- GRANULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213374
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-675 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFERASIROX90 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-675-84 | 67877067584 | 30 PACKET in 1 CARTON (67877-675-84) / 1 GRANULE in 1 PACKET (67877-675-71) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2c2842a0-7781-4047-84cd-88bd018e10c7
Use it
Look up 67877-675 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-675 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-675. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.